AU6870996A - Acylated oligopeptides containing phosphotyrosine as inhibitors of protein tyrosine kinases - Google Patents

Acylated oligopeptides containing phosphotyrosine as inhibitors of protein tyrosine kinases

Info

Publication number
AU6870996A
AU6870996A AU68709/96A AU6870996A AU6870996A AU 6870996 A AU6870996 A AU 6870996A AU 68709/96 A AU68709/96 A AU 68709/96A AU 6870996 A AU6870996 A AU 6870996A AU 6870996 A AU6870996 A AU 6870996A
Authority
AU
Australia
Prior art keywords
inhibitors
tyrosine kinases
protein tyrosine
oligopeptides containing
containing phosphotyrosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68709/96A
Other languages
English (en)
Inventor
Pascal Furet
Carlos Garcia-Echeverria
Brigitte Gay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Publication of AU6870996A publication Critical patent/AU6870996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU68709/96A 1995-08-17 1996-08-06 Acylated oligopeptides containing phosphotyrosine as inhibitors of protein tyrosine kinases Abandoned AU6870996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9516842 1995-08-17
GBGB9516842.3A GB9516842D0 (en) 1995-08-17 1995-08-17 Various acylated oligopeptides
PCT/EP1996/003479 WO1997007131A1 (fr) 1995-08-17 1996-08-06 Oligopeptides acyles divers

Publications (1)

Publication Number Publication Date
AU6870996A true AU6870996A (en) 1997-03-12

Family

ID=10779357

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68709/96A Abandoned AU6870996A (en) 1995-08-17 1996-08-06 Acylated oligopeptides containing phosphotyrosine as inhibitors of protein tyrosine kinases

Country Status (4)

Country Link
AU (1) AU6870996A (fr)
GB (1) GB9516842D0 (fr)
WO (1) WO1997007131A1 (fr)
ZA (1) ZA966968B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871436A4 (fr) * 1995-06-30 1999-10-20 Smithkline Beecham Corp UTILISATION DE COMPOSES SPECIFIQUES DU DOMAINE Stat 6 SH2 POUR LE TRAITEMENT DES REACTIONS ALLERGIQUES
GB9603227D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use
US6071707A (en) * 1996-05-07 2000-06-06 Boehringer Ingelheim Pharmaceuticals, Inc. Phosphotyrosine mimics and method for identifying and using same
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
CA2450777C (fr) 2001-08-10 2013-04-09 Novartis Ag Utilisation d'inhibiteurs c-src seuls ou en combinaison avec sti571 pour le traitement de leucemies
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
JP2010520238A (ja) 2007-03-01 2010-06-10 マリンクロット インコーポレイテッド 統合された光活性低分子および統合された光活性低分子使用
CA2773661A1 (fr) 2009-09-10 2011-03-17 Novartis Ag Derives ethers d'heteroaryles bicycliques
CN102712648A (zh) 2009-11-25 2012-10-03 诺瓦提斯公司 双环杂芳基的与苯稠合的6元含氧杂环衍生物
EP2582680A1 (fr) 2010-06-17 2013-04-24 Novartis AG Dérivés de 1,3 dihydro-benzoimidazol-2-ylidène-amine à substitution biphényle
JP2013532149A (ja) 2010-06-17 2013-08-15 ノバルティス アーゲー ピペリジニル置換１，３−ジヒドロ−ベンゾイミダゾール−２−イリデンアミン誘導体
EP2683722A1 (fr) 2011-03-08 2014-01-15 Novartis AG Composés hétéroaryliques bicycliques de type fluorophényle
EP3194572B1 (fr) 2014-07-30 2023-10-25 Yeda Research and Development Co. Ltd. Milieux pour la culture de cellules souches pluripotentes
EP3730483B1 (fr) 2017-12-21 2023-08-30 Hefei Institutes of Physical Science, Chinese Academy of Sciences Classe d'inhibiteurs de kinase dérivés de pyrimidine
EP3914698A1 (fr) 2019-01-23 2021-12-01 Yeda Research and Development Co. Ltd Milieux de culture pour cellules souches pluripotentes
US20220395553A1 (en) 2019-11-14 2022-12-15 Cohbar, Inc. Cxcr4 antagonist peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5136093A (en) * 1992-09-25 1994-04-26 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof
WO1994008600A1 (fr) * 1992-10-09 1994-04-28 Joslin Diabetes Center Inhibition de molecules transductrices de signaux

Also Published As

Publication number Publication date
ZA966968B (en) 1997-02-17
GB9516842D0 (en) 1995-10-18
WO1997007131A1 (fr) 1997-02-27

Similar Documents

Publication Publication Date Title
AU6034296A (en) Tricyclic inhibitors of protein farnesyltransferase
AU6870996A (en) Acylated oligopeptides containing phosphotyrosine as inhibitors of protein tyrosine kinases
AU2805897A (en) Inhibitors of protein farnesyltransferase
AU1529997A (en) Substituted histidine inhibitors of protein farnesyltransferase
AU5772698A (en) Inhibitors of farnesyl protein transferase
AU5324996A (en) Protein kinase c inhibitors
AU7631496A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU7371998A (en) Inhibitors of protein isoprenyl transferases
AU2136697A (en) Inhibitors of farnesyl protein transferase
AU3880897A (en) Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
AU1116497A (en) Inhibitors of cyclin-dependent kinases
AU4915796A (en) Inhibitors of prenyl transferases
AU5468499A (en) 3-methylidenyl-2-indolinone modulators of protein kinase
AU7398194A (en) Oligonucleotide modulation of protein kinase c
AU8760798A (en) Irreversible inhibitors of tyrosine kinases
AU2845395A (en) Inhibitors of farnesyl protein transferase
AU2362595A (en) Novel megakaryocytic protein tyrosine kinases
AU8681698A (en) Imidazoquinoxaline protein tyrosine kinase inhibitors
AU4328396A (en) Stabilization of liquid enzyme compositions
HUP0103520A3 (en) Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors and pharmaceutical compositions containing them
AU3482493A (en) Novel protein tyrosine kinases
AU6174696A (en) Inhibitors of phospholipase a2
AU1381499A (en) Cell-permeable protein inhibitors of calpain
AU3066699A (en) Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation
AU5329096A (en) Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases